Filing Details

Accession Number:
0001144204-11-069874
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-14 20:07:42
Reporting Period:
2011-12-12
Filing Date:
2011-12-14
Accepted Time:
2011-12-14 20:07:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Pharmathene Inc PIP Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479091 W. Jeffrey Runge C/O Pharmathene, Inc., One Park Place
Suite 450
Annapolis MD 21401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Acquisiton 2011-12-12 20,000 $1.30 20,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share 17,850 Direct
Footnotes
  1. These shares are held in the Reporting Person's IRA account.